Home 2016
Archives
FDA Approves Nuplazid for Parkinson’s Hallucinations
Half of patients with Parkinson's may experience hallucinations, delusions
Generic Crestor Approved by FDA
First generic version of Crestor (rosuvastatin calcium)
First Zika-Related Death in Puerto Rico Reported
Result of severe thrombocytopenia caused by infection with the virus
First Commercial Zika Test Approved by FDA
Quest will charge $120 for patients who don't have health insurance
FDA Reconsidering Training for Doctors Prescribing Opioids
Next week, FDA committee of outside experts will meet to review risk-management plans
FDA: Fluconazole Linked to Increased Miscarriage Risk
Agency recommends alternatives to fluconazole for mothers-to-be until its review is complete
Doctors Have a Only a Few Weeks Left to Review Financial Data
Physicians have a few weeks left to review, dispute reports relating to their financial ties to industry
U.S. Health Report Card Finds Racial, Ethnic Disparities Persist
But infant mortality rates, numbers of uninsured are improving, government analysis reveals
Direct Primary Care Is Emerging Business Model
Doctors are bypassing insurance companies in an offshoot of concierge medicine
FDA Panel Votes Against Approval of Eteplirsen for DMD
Clinical data did not meet the agency's requirements for well controlled studies necessary for approval
